|
CDTL-Mumbai analysed 382 samples as NSQ, 1 as spurious out of 5,797 samples
|
|
Swati Rana, Mumbai
July 26 , 2016
|
|
|
The Central Drug Testing Laboratory (CDTL)- Mumbai completed the task of
analysing 5,797 samples of National Drug Survey Samples received
through National Institute of Biologicals (NIB), Noida. The lab has
declared 382 samples as Not of Standard Quality (NSQ) and declared 1
sample as spurious.
The lab started receiving the samples since
June, 2015 till May, 2016; hired and trained nearly 40 contractual staff
with the approval of ministry to meet the deadline and deliver the
report on time. The lab has submitted the report in the month of June,
2016
Dr. Raman Mohan Singh, director of CDTL, Mumbai, says: “We
have successfully analysed the samples we received from NIB and
submitted our final report. We are awaiting the final report from the
government which probably be out by this month end. In case of further
action CDSCO is already training the drug inspector, government analyst
and lab analyst for further inspection.”
He further says, “The
staff and officers have taken every single effort for speedy analysis of
the molecules allotted to the laboratory.
The Ministry supported
this venture by sanctioning 35 more contractual posts, 25 recruited in
July 2015 and 10 in December 2015. These includes 25 Bench Chemists and
05 Supporting Staff who have worked up to March 2016 in the laboratory.”
It
was also informed by the source that the CDSCO has already initiated
the inspection of pharmaceutical manufacturing unit whose drug were
analysed as not of standard quality.
The CDSCO initiated the
National Drug Survey Plan in consultation with NIB to put an end to the
conflicting views related to the spurious drugs and drugs not of
standard quality. Overall 47, 000 samples were collected and sent to
Central Drug Testing Labs in Chandigarh, Mumbai, Hyderabad, Chennai,
Kolkata and Guwahati, state drugs testing labs at Gujarat, Karnataka,
Maharashtra and a lab at Indian Pharmacopoeia Commission (IPC),
Ghaziabad for testing and analysis.
|
|
|
|
|
|
|
|
TOPICS
|
That foods might provide therapeutic benefits is clearly not a new concept. ...
|
|
|
|
|